Literature DB >> 8636083

Differential effects of the protein kinase C activator phorbol 12-myristate 13-acetate on calcium responses and secretion in adherent and suspended RBL-2H3 mucosal mast cells.

P C Wolfe1, E Y Chang, J Rivera, C Fewtrell.   

Abstract

Adhesion of RBL-2H3 mucosal mast cells to fibronectin-coated surfaces has been linked to changes in secretion and tyrosine kinase activity. We now show that adhesion affects the sensitivity of RBL cells to the protein kinase C activator phorbol 12-myristate 13-acetate (PMA). In suspended cells, PMA inhibited antigen-induced calcium influx (as measured by manganese influx) and changes in intracellular free calcium and had complex effects on antigen-stimulated secretion. However, in adherent cells PMA had little effect on these responses. Suspended cells only secreted in response to thapsigargin if they were co-treated with PMA, while adherent cells secreted in response to thapsigargin alone. The thapsigargin-induced secretion in adherent cells was inhibited by protein kinase C down-regulation and by the protein kinase C inhibitor GF 109203X, but not by calphostin C. We suggest that protein kinase C is constitutively activated in adherent cells, possibly due to modification of the regulatory domain of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636083     DOI: 10.1074/jbc.271.12.6658

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Microdomains of high calcium are not required for exocytosis in RBL-2H3 mucosal mast cells.

Authors:  S F Mahmoud; C Fewtrell
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

2.  Antimicrobial agent triclosan suppresses mast cell signaling via phospholipase D inhibition.

Authors:  Juyoung K Shim; Molly A Caron; Lisa M Weatherly; Logan B Gerchman; Suraj Sangroula; Siham Hattab; Alan Y Baez; Talya J Briana; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2019-08-19       Impact factor: 3.446

3.  Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.

Authors:  T Miyakawa; M Kojima; M Ui
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Molecular mechanisms of spontaneous and directed mast cell motility.

Authors:  Jinmin Lee; Sarah L Veatch; Barbara Baird; David Holowka
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

Review 5.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

6.  Sphingosine derivatives inhibit cell signaling by electrostatically neutralizing polyphosphoinositides at the plasma membrane.

Authors:  Norah L Smith; Stephanie Hammond; Deepti Gadi; Alice Wagenknecht-Wiesner; Barbara Baird; David Holowka
Journal:  Self Nonself       Date:  2010

7.  Sequestration of phosphoinositides by mutated MARCKS effector domain inhibits stimulated Ca(2+) mobilization and degranulation in mast cells.

Authors:  Deepti Gadi; Alice Wagenknecht-Wiesner; David Holowka; Barbara Baird
Journal:  Mol Biol Cell       Date:  2011-10-19       Impact factor: 4.138

8.  CD45 exclusion- and cross-linking-based receptor signaling together broaden FcεRI reactivity.

Authors:  James H Felce; Erdinc Sezgin; Madina Wane; Heather Brouwer; Michael L Dustin; Christian Eggeling; Simon J Davis
Journal:  Sci Signal       Date:  2018-12-18       Impact factor: 9.517

9.  Impaired degranulation but enhanced cytokine production after Fc epsilonRI stimulation of diacylglycerol kinase zeta-deficient mast cells.

Authors:  Benjamin A Olenchock; Rishu Guo; Michael A Silverman; Jennifer N Wu; Jeffery H Carpenter; Gary A Koretzky; Xiao-Ping Zhong
Journal:  J Exp Med       Date:  2006-05-22       Impact factor: 14.307

10.  Roles for ca(2+) mobilization and its regulation in mast cell functions.

Authors:  David Holowka; Nathaniel Calloway; Roy Cohen; Deepti Gadi; Jinmin Lee; Norah L Smith; Barbara Baird
Journal:  Front Immunol       Date:  2012-05-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.